General practitioners prefer prescribing indicators based on detailed information on individual patients: A Delphi study

European Journal of Clinical Pharmacology

Volumn 61, Issue 3, 2005, Pages 237-241

  Rasmussen, Hanne M S ^a   Søndergaard, Jens ^a   Kampmann, Jens P ^a   Andersen, Morten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Delphi technique; Prescribing indicators; Quality of prescribing

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIULCER AGENT; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; ROFECOXIB;

ANAMNESIS; ARTICLE; CONTROLLED STUDY; DENMARK; DRUG COST; GENERAL PRACTITIONER; HUMAN; PATIENT INFORMATION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RATING SCALE; REGISTER; SIDE EFFECT; STATISTICAL MODEL; VALIDATION PROCESS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONSENSUS; DELPHI TECHNIQUE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG; REGISTRIES;

EID: 20044383046     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0870-9     Document Type: Article

References (26)

1. Bateman DN, Eccles M, Campbell M, Soutier J, Roberts SJ, Smith JM (1996) Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract 46:20-25
2. Steffensen FH, Schonheyder HC, Sorensen HT (1997) High prescribers of antibiotics among general practitioners - relation to prescribing habits of other drugs and use of microbiological diagnostics. Scand J Infect Dis 29:409-413
3. Avery AJ, Heron T, Lloyd D, Harris CM, Roberts D (1998) Investigating relationships between a range of potential indicators of general practice prescribing: an observational study. J Clin Pharm Ther 23:441-450
4. Campbell SM, Cantrill JA, Roberts D (2000) Prescribing indicators for UK general practice: Delphi consultation study. BMJ 321:425-428
5. Coste J, Venot A (1999) An epidemiologic approach to drug prescribing quality assessment: a study in primary care practice in France. Med Care 37:1294-1307
6. Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM (2001) Comparison of indicators assessing the quality of drug prescribing for asthma. Health Serv Res 36:143-161
7. Cantrill JA, Sibbald B, Buetow S (1998) Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care 7:130-135
8. Majeed A, Evans N, Head P (1997) What can PACT tell us about prescribing in general practice? BMJ 315:1515-1519
9. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, et al (1998) Drug utilization 90% - a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 54:113-118
10. Søndergaard J, Andersen M, Kragstrup J, Hansen P, Freng GL (2002) Why has postal prescriber feedback no substantial impact on general practitioners' prescribing practice? A qualitative study. Eur J Clin Pharmacol 58:133-136
11. Glintborg D, Unkerskov J, Bach KF, Rasmussen H, Kampmann JP (2002) [NSAID - controversies]. Rationel Farmakoterapi 8:1-4 (in Danish)
12. Robertson J, Fryer JL, O'Connell DL, Smith AJ, Henry DA (2001) Personal formularies. An index of prescribing quality? Eur J Clin Pharmacol 57:333-341
13. Henry D, Lim LL, Garcia Rodriguez LA, Perez GS, Carson JL, Griffin M, et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312:1563-1566
14. Laine L (2001) Approaches to non-steroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120:594-606
15. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al (1998) Omeprazole compared with misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-Induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 338:727-734
16. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al (1998) A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal anti-inflammatory drugs Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-Associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 338:719-726
17. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE (2002) Dose-response relationships between individual nonaspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 54:320-326
18. Barber N (1995) What constitutes good prescribing? BMJ 310:923-925
19. Dean B, Barber N, Schachter M (2000) What is a prescribing error? Qual Health Care 9:232-237
20. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, van het Loo M, et al (assessed December 2002) The RAND/UCLA Appropriateness Method User's Manual. http://www.rand.org/publications/MR/MR1269/
21. Jones J, Hunter D (1995) Consensus methods for medical and health services research. BMJ 311:376-380
22. Cantrill JA, Sibbald B, Buetow S (1996) The Delphi and nominal group techniques in health services research. Int J Pharm Pract 4:67-74
23. Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445-448
24. Campbell SM, Hann M, Roland MO, Quayle JA, Shekelle PG (1999) The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care 37:964-968
25. Seager JM, Cullen DJ, Pearson G, Holmes S, Doherty M, Wilson JV, et al (2000) Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perception. Aliment Pharmacol Ther 14:187-191
26. Pont LG, Denig P, van der Molen T, van der Veen WJ, Haaijer-Ruskamp FM (2004) Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol 59(11):833-840